Page 33 - 《中国药房》2026年3期
P. 33

·药学研究·


          补阳还五汤及其有效部位改善非酒精性脂肪性肝病的作用及机
          制研究
                    Δ


                                                                       #
          杨金彪 ,陈星彤,周云越,杨蕊红,王 乔,薛 爽,张玉昆,牛雯颖(黑龙江中医药大学基础医学院,哈尔滨
                *
          150040)

          中图分类号  R965      文献标志码  A      文章编号  1001-0408(2026)03-0299-06
          DOI  10.6039/j.issn.1001-0408.2026.03.05

          摘  要  目的  研究补阳还五汤(BYHWD)及其有效部位改善非酒精性脂肪性肝病的作用及机制。方法  制备 BYHWD 及其醇
          沉、30%乙醇、50%乙醇、75%乙醇有效部位(即CC、30YC、50YC、75YC有效部位),以此灌胃大鼠并制备相应含药血清(同法制备
          空白血清和辛伐他汀含药血清)。将人L02肝细胞分为对照组、模型组、辛伐他汀含药血清组、BYHWD含药血清组、CC含药血清
          组、30YC含药血清组、50YC含药血清组、75YC含药血清组。除对照组外,其余各组均加入0.2 mol/L油酸诱导24 h,以建立脂质沉
          积模型,再加入相应 20% 含药血清/空白血清干预 24 h。观察细胞中脂质沉积情况,并计算脂滴面积占比;检测细胞中甘油三酯
         (TG)及氧化应激[丙二醛(MDA)、超氧化物歧化酶(SOD)]、肝功能[丙氨酸氨基转移酶(ALT)、天冬氨酸氨基转移酶(AST)]指标
          水平;检测细胞中AMP活化的蛋白质激酶(AMPK)/固醇调节元件结合蛋白1(SREBP-1)/甘油-3-磷酸酰基转移酶(GPAT)信号通
          路相关蛋白及mRNA表达水平。结果  与对照组比较,模型组细胞脂肪变性严重,细胞中脂滴面积占比以及TG、ALT、AST、MDA
          水平和SREBP-1、GPAT mRNA及其蛋白表达水平均显著升高(P<0.05),细胞中SOD水平、AMPK mRNA表达水平和AMPK蛋白
          磷酸化水平均显著降低(P<0.05)。与模型组比较,各含药血清组细胞脂肪变性均减轻,上述大部分定量指标水平均被显著逆转
         (P<0.05)。结论  BYHWD及其有效部位可通过调控AMPK/SREBP-1/GPAT信号通路,抑制氧化应激反应,减轻脂质沉积,从而
          发挥改善非酒精性脂肪性肝病的作用。
          关键词  补阳还五汤;非酒精性脂肪性肝病;脂质沉积;AMPK/SREBP-1/GPAT信号通路;氧化应激

          Ameliorative effects and mechanisms of Buyang huanwu decoction and its active fractions on non-alcoholic
          fatty liver disease
          YANG Jinbiao,CHEN Xingtong,ZHOU Yunyue,YANG Ruihong,WANG Qiao,XUE Shuang,ZHANG Yukun,
          NIU Wenying(School  of  Basic  Medical  Sciences,  Heilongjiang  University  of  Chinese  Medicine,  Harbin
          150040, China)

          ABSTRACT   OBJECTIVE  To  investigate  the  effects  and  mechanisms  of  Buyang  huanwu  decoction (BYHWD)  and  its  active
          fractions in ameliorating non-alcoholic fatty liver disease. METHODS BYHWD and its effective fractions obtained through ethanol
          precipitation, as well as 30% ethanol, 50% ethanol, and 75% ethanol fractions (namely, the CC effective fraction, 30YC effective
          fraction,  50YC  effective  fraction,  and  75YC  effective  fraction),  were  prepared.  These  preparations  were  administered  to  rats  via
          intragastric  administration  to  prepare  corresponding  drug-containing  serum (blank  serum  and  simvastatin-containing  serum  were
          prepared  using  the  same  protocol).  Human  L02  hepatocytes  were  divided  into  control  group,  model  group,  simvastatin-containing
          serum  group,  BYHWD-containing  serum  group,  CC-containing  serum  group,  30YC-containing  serum  group,  50YC-containing
          serum group, and 75YC-containing serum group. Except for the control group, other groups were given 0.2 mol/L oleic acid for 24 h
          to  induce  a  lipid  accumulation  model,  and  then  intervened  with  20%  drug-containing  serum/blank  serum  for  24  h.  The  lipid
          deposition  in  cells  was  observed,  and  the  proportion  of  lipid  droplet  area  was  calculated;  the  levels  of  triglycerides (TG)  and
          indicators  of  oxidative  stress  [malondialdehyde (MDA),  superoxide  dismutase (SOD)]  as  well  as  liver  function  [alanine  amino-
          transferase (ALT), aspartate amino-transferase (AST)] in cells were detected; protein and mRNA expressions of     AMP-activated
                                                             protein  kinase  (AMPK)/sterol  regulatory  element-binding
             Δ 基金项目 国家自然科学基金项目(No.82274405)                  protein-1  (SREBP-1)/glycerol-3-phosphate   acyltransferase
             *第一作者 硕士研究生。研究方向:中药药理学。E-mail:
          2802157592@qq.com                                 (GPAT)  signaling  pathway  were  also  measured.  RESULTS
             # 通信作者 研究员,博士,硕士生导师。研究方向:中药药理学。                 Compared  with  the  control  group,  cells  in  the  model  group
          E-mail:nwy012603001@126.com                        exhibited  severe  cellular  steatosis,  with  a  significantly


          中国药房  2026年第37卷第3期                                                 China Pharmacy  2026 Vol. 37  No. 3    · 299 ·
   28   29   30   31   32   33   34   35   36   37   38